In yesterday’s Wall Street session, Edwards Lifesciences Corp (NYSE:EW) shares traded at $71.13, down -1.97% from the previous session.
EW stock price is now -1.14% away from the 50-day moving average and -6.15% away from the 200-day moving average. The market capitalization of the company currently stands at $41.95B.
With the price target maintained at $60, Wolfe Research recently Downgraded its rating from Peer Perform to Underperform for Edwards Lifesciences Corp (NYSE: EW). , while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
In other news, Lippis Daniel J., CVP, JAPAC sold 500 shares of the company’s stock on Jan 16 ’25. The stock was sold for $34,382 at an average price of $68.76. Upon completion of the transaction, the CVP, JAPAC now directly owns 23,189 shares in the company, valued at $1.65 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 16 ’25, CVP,Strategy/Corp Development BOBO DONALD E JR sold 5,000 shares of the business’s stock. A total of $343,736 was realized by selling the stock at an average price of $68.75. This leaves the insider owning 46,936 shares of the company worth $3.34 million. A total of 1.79% of the company’s stock is owned by insiders.
During the past 12 months, Edwards Lifesciences Corp has had a low of $58.93 and a high of $96.12. As of last week, the company has a debt-to-equity ratio of 0.07, a current ratio of 3.46, and a quick ratio of 2.89. According to the stock market information, the enterprise value for the company is $38278873088, which is based on a 10.26 price-to-earnings ratio, a 3.42 price-to-earnings-growth ratio, and a beta of 1.10. The fifty day moving average price for EW is $71.9532 and a two-hundred day moving average price translates $75.788 for the stock.
The latest earnings results from Edwards Lifesciences Corp (NYSE: EW) was released for 2024-09-30. The net profit margin was 70.82% and return on equity was 17.93% for EW. The company reported revenue of $1.35 billion for the quarter, compared to $1.24 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.93 percent.
